Inducing In Situ Functional Maturation of Transplanted Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes: Establishing Strategies for Treating Myocardial Injury
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202503799 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xueqin Shi und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Tenth Affiliated Hospital (Dongguan People's Hospital), Shenzhen School of Clinical Medicine, Southern Medical University, Dongguan, 523059, Chin…. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Myocytes, Cardiac, Myocardial Infarction. Die Arbeit nennt 77 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Funded Postdoctoral Researcher Program.
Abstract (Originalsprache)
Human induced pluripotent stem cell‐derived cardiomyocytes (hiPSC‐CMs) have demonstrated significant potential for the treatment of heart diseases. However, hiPSC‐CMs generated by the current methods still exhibit structural and electrophysiological immaturity, resembling fetal cardiomyocytes. Although various strategies have been developed to promote in vitro maturation, cell loss and death remain persistent challenges during transplantation. Therefore, a multipronged approach is developed to induce in situ hiPSC‐CMs functional maturation and enhance the cell transplantation rate, not only allowing cells carried within to have lower automatism, but also retaining the ability to restore systolic function. Chitosan is used as the matrix backbone to form a unique 3D network structure for cell encapsulation and delivery, whereas anionic lipid‐based carriers derived from negatively charged liposomes enabled pH‐responsive release of the mammalian target of rapamycin (mTOR) inhibitor within the weakly acidic microenvironment in myocardial infarction. Inhibition of the mTOR‐signaling pathway can promote the functional maturation of hiPSC‐CMs by bringing them into a quiescent state, allowing the cells not only to have lower automatism but also to resume pulsation under slight stimulation. This approach promotes the functional recovery of injured hearts by enhancing more robust gap junctions and angiogenesis in infarcted mouse hearts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Tenth Affiliated Hospital (Dongguan People's Hospital), Shenzhen School of Clinical Medicine, Southern Medical University, Dongguan, 523059, China.
- State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
- The Affiliated Panyu Central Hospital, Guangzhou Medical University, Guangzhou, 510515, China.
- Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangzhou, 510515, China.
ORCID-Profile: Caiwen Ou
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Funded Postdoctoral Researcher Program
- Medical Scientific Research Foundation of Guangdong Province
- Dongguan Science and Technology of Social Development Program
- National Key Research and Development Program of China
Zitieren
APA
Shi, X., Zhong, J., Liu, X., Guo, S., Li, W., Zhang, J., Ning, X., Liu, Y., Zhang, C., Zhong, Q., Zhang, Z., Guan, T., Chen, P., & Ou, C. (2026). Inducing In Situ Functional Maturation of Transplanted Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes: Establishing Strategies for Treating Myocardial Injury. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202503799
Vancouver
Shi X, Zhong J, Liu X, Guo S, Li W, Zhang J, et al. Inducing In Situ Functional Maturation of Transplanted Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes: Establishing Strategies for Treating Myocardial Injury. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202503799
BibTeX
@article{Shi2026,
author = {Shi, Xueqin and Zhong, Jianfeng and Liu, Xueting and Guo, Shuai and Li, Weirun and Zhang, Jiexin and Ning, Xiaodong and Liu, Yuhua and Zhang, Chi and Zhong, Qiujian and Zhang, Zhilong and Guan, Tianwang and Chen, Peier and Ou, Caiwen},
title = {Inducing In Situ Functional Maturation of Transplanted Human Induced Pluripotent Stem Cell‐Derived Cardiomyocytes: Establishing Strategies for Treating Myocardial Injury},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202503799}
}
EUVIMED